Aminov Erez 4
4 · MIRA PHARMACEUTICALS, INC. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Aminov Erez
DirectorCEO and Chairman
Transactions
- Award
Common Stock
2025-10-01+2,685,456→ 3,530,156 total
Footnotes (1)
- [F1]Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.